表紙
市場調查報告書
商品編碼
1043568

成藥(OTC)的全球市場:各產品,各給藥途徑,各劑型,各流通管道,各地區:競爭,預測及機會-2026年

Global Over the Counter Drugs Market, By Product, By Route of Administration, By Dosage Form, By Distribution Channel, By Region, Competition, Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球成藥的市場規模,預計在預測期間內預計以9.86%的年複合成長率成長,2026年達到2,741億5,000萬美元。

今後的市場成長,由於發展中國家對一般疾病的成藥使用增加,需求預計增加。由於醫療費增加,對有效治療的需求劇增,今後5年,預計全球成藥市場成長。還有線上藥局急速增加,需要基本處方箋,不過複數的成藥沒有處方箋也能購買。因此,今後5年預計支撐全球成藥市場成長。

本報告提供全球成藥市場相關調查分析,COVID-19影響,全球市場預測,北美、歐洲、亞太地區、南美、中東、非洲市場預測,市場動態,競爭情形等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球成藥(OTC)市場的影響

第4章 摘要整理

第5章 客戶的迴響

  • 品牌認知度
  • 一般的成藥:各產品
  • 優先購買點
  • 未支援的需求/課題

第6章 全球成藥(OTC)市場預測

  • 市場規模與預測
    • 金額和各數量
  • 市場佔有率與預測
    • 各產品(咳嗽,感冒、流感、 維他命,礦泉水,補充品(VMS),止痛藥,消化器官用藥,皮膚科用藥,其他)
    • 各給藥途徑(口服,非口服,局部,其他)
    • 各劑型(錠劑,膠囊,液體、溶液,奶油、化妝水、軟膏,其他)
    • 各流通管道(零售藥局,醫院藥局,E藥局)
    • 各地區
    • 各企業(2020)
  • 產品市場地圖

第7章 北美的成藥(OTC)市場預測

  • 市場規模與預測
    • 金額和各數量
  • 市場佔有率與預測
    • 各產品
    • 各給藥途徑
    • 各劑型
    • 各流通管道
    • 各國
  • 北美:各國分析
    • 美國
    • 加拿大
    • 墨西哥

第8章 歐洲的成藥(OTC)市場預測

  • 市場規模與預測
    • 金額和各數量
  • 市場佔有率與預測
    • 各產品
    • 各給藥途徑
    • 各劑型
    • 各流通管道
    • 各國
  • 歐洲:各國分析
    • 德國
    • 英國
    • 義大利
    • 西班牙
    • 法國

第9章 亞太地區的成藥(OTC)市場預測

  • 市場規模與預測
    • 金額和各數量
  • 市場佔有率與預測
    • 各產品
    • 各給藥途徑
    • 各劑型
    • 各流通管道
    • 各國
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國

第10章 南美的成藥(OTC)市場預測

  • 市場規模與預測
    • 金額和各數量
  • 市場佔有率與預測
    • 各產品
    • 各給藥途徑
    • 各劑型
    • 各流通管道
    • 各國
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章 中東及非洲的成藥(OTC)市場預測

  • 市場規模與預測
    • 金額和各數量
  • 市場佔有率與預測
    • 各產品
    • 各給藥途徑
    • 各劑型
    • 各流通管道
    • 各國
  • 中東、非洲:各國分析
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • Johnson & Johnson
  • Bayer AG
  • Novartis AG
  • GlaxoSmithKline Plc.-Pfizer, Inc.
  • Sanofi S.A.
  • Perrigo Company Plc.
  • Reckitt Benckiser Group Plc.
  • Sun Pharmaceutical Industries Ltd.
  • The Procter & Gamble Company
  • Teva Pharmaceutical Industries Limited
  • Dr. Reddy's Laboratories Ltd.
  • Zydus Takeda Healthcare Pvt. Ltd.
  • Mylan NV
  • Cipla Ltd.
  • Alkem Laboratories Limited

第15章 策略性推薦事項

第16章 關於我們&免責聲明

目錄
Product Code: 5054

Global Over the Counter (OTC) drugs market is anticipated to grow at CAGR of 9.86% through 2026 to reach USD274.15 billion by the end of forecast period, 2026. Future growth of the global over the counter (OTC) drugs market can be attributed to increasing demand emanating from the developing countries due to increasing use of these drugs for common disease conditions. Over the counter (OTC) drugs have higher market penetration in developing countries like India, China, Kenya, etc., and as a result there is high affordability and accessibility of OTC drugs.

With increasing healthcare expenditures and surging demand for the effective treatment, growth of the global over the counter (OTC) drugs market is evident for next five years. Moreover, online pharmacies are increasing rapidly. Although, the demand for prescription is mandatory for various online platforms, multiple over the counter drugs are available without the prescription from these online pharmacies. Thus, consumers are able to easily order their medicines from the online sources and avoid long queues at the traditional offline pharmacies, thereby supporting the growth of the global over the counter drugs market in the future five years.

Although, over the counter drugs market lacks classification. With present concerns over ill-monitored dozing and increased drug abusing instances, the global over the counter drugs market might suffer in the future growth. Proper channeling and maintained distribution of the over the counter drugs may support to overcome the short comings of the market and support future growth in the forecast years.

The OTC drugs market is segmented based on product, route of administration, dosage form, distribution channel, region, and company. Based on route of administration, the market can be segregated into oral, parenteral, topical, and others. The oral route of administration is anticipated to hold the largest revenue shares and dominate the market segment in the upcoming five years on the account of its simplicity. Most of the over the counter drugs available in the market are administered orally that may be in capsule, tablet, or syrup form. Also, the administration procedure is convenient. The patient does not require help from caretaker for the administration which is a requirement during administering parenteral dosage of drugs. Parenteral administration is also anticipated to register significant growth in the next five years on the grounds of effectivity of the drugs when administered in parenteral form.

Major players operating in the global over the counter (OTC) drugs market include Johnson & Johnson, Bayer AG, Novartis AG, GlaxoSmithKline Plc.-Pfizer, Inc., Sanofi S.A., Perrigo Company Plc., Reckitt Benckiser Group Plc., Sun Pharmaceutical Industries Ltd., The Procter & Gamble Company, Teva Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Zydus Takeda Healthcare Pvt. Ltd., Mylan NV, Cipla Ltd., Alkem Laboratories Limited, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of global over the counter (OTC) drugs market from 2016 to 2020.
  • To estimate and forecast the market size of global over the counter (OTC) drugs market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global over the counter (OTC) drugs market based on product, route of administration, dosage form, distribution channel, region, and company and regional distribution.
  • To identify dominant region or segment in the global over the counter (OTC) drugs market.
  • To identify drivers and challenges for global over the counter (OTC) drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global over the counter (OTC) drugs market.
  • To identify and analyze the profile of leading players operating in global over the counter (OTC) drugs market.
  • To identify key sustainable strategies adopted by market players in global over the counter (OTC) drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global over the counter (OTC) drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Over the counter drugs manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to over the counter drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global over the counter (OTC) drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Over the Counter (OTC) Drugs Market, By Product:

Cough, Cold, & Flu,

Vitamins, Mineral & Supplements (VMS)

Analgesics

Gastrointestinal Products

Dermatology Products

Others

  • Over the Counter (OTC) Drugs Market, By Route of Administration:

Oral

Parenteral

Topical

Others

  • Over the Counter (OTC) Drugs Market, By Dosage Form:

Tablets

Capsules

Liquids & Solutions

Cream/Lotion/Ointments

Others

  • Over the Counter (OTC) Drugs Market, By Distribution Channel:

Retail Pharmacy

Hospital Pharmacy

E-Pharmacy

  • Over the Counter (OTC) Drugs Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • United Kingdom
  • Italy
  • Spain
  • France

Asia-Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Over the Counter (OTC) Drugs Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Commonly Sold Over the Counter (OTC) Drugs, By Product
  • 5.3. Preferred Point of Purchase
  • 5.4. Unmet Needs/Challenges

6. Global Over the Counter (OTC) Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Cough, Cold & Flu, Vitamins, Mineral, and Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others)
    • 6.2.2. By Route of Administration (Oral, Parenteral, Topical, Others)
    • 6.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others)
    • 6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
    • 6.2.5. By Region
    • 6.2.6. By Company (2020)
  • 6.3. Product Market Map

7. North America Over the Counter (OTC) Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Route of Administration
    • 7.2.3. By Dosage Form
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Over the Counter (OTC) Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By Dosage Form
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Canada Over the Counter (OTC) Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By Dosage Form
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Mexico Over the Counter (OTC) Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By Dosage Form
        • 7.3.3.2.4. By Distribution Channel

8. Europe Over the Counter (OTC) Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Route of Administration
    • 8.2.3. By Dosage Form
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Over the Counter (OTC) Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Dosage Form
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. United Kingdom Over the Counter (OTC) Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Dosage Form
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Italy Over the Counter (OTC) Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Dosage Form
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Spain Over the Counter (OTC) Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By Dosage Form
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. France Over the Counter (OTC) Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By Dosage Form
        • 8.3.5.2.4. By Distribution Channel

9. Asia-Pacific Over the Counter (OTC) Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Route of Administration
    • 9.2.3. By Dosage Form
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Over the Counter (OTC) Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Dosage Form
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. India Over the Counter (OTC) Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Dosage Form
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Japan Over the Counter (OTC) Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Dosage Form
        • 9.3.3.2.4. By Distribution Channel
    • 9.3.4. Australia Over the Counter (OTC) Drugs Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Route of Administration
        • 9.3.4.2.3. By Dosage Form
        • 9.3.4.2.4. By Distribution Channel
    • 9.3.5. South Korea Over the Counter (OTC) Drugs Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Route of Administration
        • 9.3.5.2.3. By Dosage Form
        • 9.3.5.2.4. By Distribution Channel

10. South America Over the Counter (OTC) Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Route of Administration
    • 10.2.3. By Dosage Form
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Over the Counter (OTC) Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By Dosage Form
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Argentina Over the Counter (OTC) Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By Dosage Form
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. Colombia Over the Counter (OTC) Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By Dosage Form
        • 10.3.3.2.4. By Distribution Channel

11. Middle East and Africa Over the Counter (OTC) Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Route of Administration
    • 11.2.3. By Dosage Form
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. Saudi Arabia Over the Counter (OTC) Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Route of Administration
        • 11.3.1.2.3. By Dosage Form
        • 11.3.1.2.4. By Distribution Channel
    • 11.3.2. South Africa Over the Counter (OTC) Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Route of Administration
        • 11.3.2.2.3. By Dosage Form
        • 11.3.2.2.4. By Distribution Channel
    • 11.3.3. UAE Over the Counter (OTC) Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Route of Administration
        • 11.3.3.2.3. By Dosage Form
        • 11.3.3.2.4. By Distribution Channel
    • 11.3.4. Kuwait Over the Counter (OTC) Drugs Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.2. By Route of Administration
        • 11.3.4.2.3. By Dosage Form
        • 11.3.4.2.4. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends and Developments

14. Competitive Landscape

  • 14.1. Johnson & Johnson
  • 14.2. Bayer AG
  • 14.3. Novartis AG
  • 14.4. GlaxoSmithKline Plc.-Pfizer, Inc.
  • 14.5. Sanofi S.A.
  • 14.6. Perrigo Company Plc.
  • 14.7. Reckitt Benckiser Group Plc.
  • 14.8. Sun Pharmaceutical Industries Ltd.
  • 14.9. The Procter & Gamble Company
  • 14.10. Teva Pharmaceutical Industries Limited
  • 14.11. Dr. Reddy's Laboratories Ltd.
  • 14.12. Zydus Takeda Healthcare Pvt. Ltd.
  • 14.13. Mylan NV
  • 14.14. Cipla Ltd.
  • 14.15. Alkem Laboratories Limited

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
  • Figure 3: Global Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 4: Global Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 5: Global Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 6: Global Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 7: Global Over the Counter (OTC) Drugs Market Share, By Region, By Value, 2016-2026F
  • Figure 8: Global Over the Counter (OTC) Drugs Market Share, By Company, By Value, 2020
  • Figure 9: North America Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 10: North America Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
  • Figure 11: North America Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 12: North America Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 13: North America Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 14: North America Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 15: North America Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 16: United States Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 17: United States Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 18: United States Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 19: United States Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 20: United States Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 21: Canada Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 22: Canada Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 23: Canada Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 24: Canada Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 25: Canada Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 26: Mexico Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 27: Mexico Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 28: Mexico Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 29: Mexico Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 30: Mexico Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 31: Europe Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 32: Europe Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
  • Figure 33: Europe Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 34: Europe Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 35: Europe Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 36: Europe Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 37: Europe Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 38: Germany Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 39: Germany Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 40: Germany Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 41: Germany Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 42: Germany Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 43: United Kingdom Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 44: United Kingdom Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 45: United Kingdom Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 46: United Kingdom Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 47: United Kingdom Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 48: Italy Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 49: Italy Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 50: Italy Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 51: Italy Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 52: Italy Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 53: Spain Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 54: Spain Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 55: Spain Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 56: Spain Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 57: Spain Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 58: France Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 59: France Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 60: France Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 61: France Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 62: France Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 63: Asia Pacific Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 64: Asia Pacific Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
  • Figure 65: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 66: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 67: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 68: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 69: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 70: China Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 71: China Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 72: China Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 73: China Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 74: China Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 75: India Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 76: India Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 77: India Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 78: India Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 79: India Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 80: Japan Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 81: Japan Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 82: Japan Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 83: Japan Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 84: Japan Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 85: Australia Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 86: Australia Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 87: Australia Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 88: Australia Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 89: Australia Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 90: South Korea Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 91: South Korea Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 92: South Korea Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 93: South Korea Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 94: South Korea Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 95: South America Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 96: South America Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
  • Figure 97: South America Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 98: South America Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 99: South America Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 100: South America Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 101: South America Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 102: Brazil Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 103: Brazil Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 104: Brazil Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 105: Brazil Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 106: Brazil Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 107: Argentina Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 108: Argentina Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 109: Argentina Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 110: Argentina Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 111: Argentina Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 112: Colombia Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 113: Colombia Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 114: Colombia Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 115: Colombia Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 116: Colombia Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 117: Middle East & Africa Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 118: Middle East & Africa Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
  • Figure 119: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 120: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 121: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 122: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 123: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 124: Saudi Arabia Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 125: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 126: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 127: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 128: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 129: South Africa Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 130: South Africa Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 131: South Africa Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 132: South Africa Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 133: South Africa Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 134: UAE Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 135: UAE Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 136: UAE Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 137: UAE Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 138: UAE Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 139: Kuwait Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 140: Kuwait Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
  • Figure 141: Kuwait Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 142: Kuwait Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 143: Kuwait Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F